187 related articles for article (PubMed ID: 22593586)
1. MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene.
Fang R; Xiao T; Fang Z; Sun Y; Li F; Gao Y; Feng Y; Li L; Wang Y; Liu X; Chen H; Liu XY; Ji H
J Biol Chem; 2012 Jun; 287(27):23227-35. PubMed ID: 22593586
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA regulation and analytical methods in cancer cell metabolism.
Zhang LF; Jiang S; Liu MF
Cell Mol Life Sci; 2017 Aug; 74(16):2929-2941. PubMed ID: 28321489
[TBL] [Abstract][Full Text] [Related]
3. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.
Zhang L; Jiang C; Zhong Y; Sun K; Jing H; Song J; Xie J; Zhou Y; Tian M; Zhang C; Sun X; Wang S; Cheng X; Zhang Y; Wei W; Li X; Fu B; Feng P; Wu B; Shu HB; Zhang J
Nat Cell Biol; 2023 Aug; 25(8):1208-1222. PubMed ID: 37443289
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells.
Gregersen LH; Jacobsen A; Frankel LB; Wen J; Krogh A; Lund AH
BMC Cancer; 2012 Jun; 12():232. PubMed ID: 22691140
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Kojima S; Kinoshita T; Tatarano S; Chiyomaru T; Nakagawa M; Seki N
Cancer Sci; 2013 Dec; 104(12):1567-74. PubMed ID: 24033605
[TBL] [Abstract][Full Text] [Related]
6. Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy.
Li XB; Gu JD; Zhou QH
Thorac Cancer; 2015 Jan; 6(1):17-24. PubMed ID: 26273330
[TBL] [Abstract][Full Text] [Related]
7. The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.
Feng Y; Wang Y; Wang Z; Fang Z; Li F; Gao Y; Liu H; Xiao T; Li F; Zhou Y; Zhai Q; Liu X; Sun Y; Bardeesy N; Wong KK; Chen H; Xiong ZQ; Ji H
Cancer Res; 2012 Dec; 72(24):6502-11. PubMed ID: 23074285
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems.
Tang H; Lee M; Sharpe O; Salamone L; Noonan EJ; Hoang CD; Levine S; Robinson WH; Shrager JB
FASEB J; 2012 Nov; 26(11):4710-21. PubMed ID: 22767230
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.
Chang J; Liu Y; Han B; Zhou C; Bai C; Li J
Med Oncol; 2015 May; 32(5):139. PubMed ID: 25801231
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
Soejima K; Naoki K; Ishioka K; Nakamura M; Nakatani M; Kawada I; Watanabe H; Nakachi I; Yasuda H; Satomi R; Nakayama S; Yoda S; Ikemura S; Terai H; Sato T; Ohgino K; Arai D; Tani T; Kuroda A; Nishino M; Betsuyaku T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):513-9. PubMed ID: 25563719
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of a copper (II) complex of a coumarin derivative and phenanthroline on lung adenocarcinoma cells and the mechanism of action.
Zhu T; Chen R; Yu H; Feng Y; Chen J; Lu Q; Xie J; Ding W; Ma T
Mol Med Rep; 2014 Nov; 10(5):2477-82. PubMed ID: 25176185
[TBL] [Abstract][Full Text] [Related]
12. YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression.
Gao Y; Zhang W; Han X; Li F; Wang X; Wang R; Fang Z; Tong X; Yao S; Li F; Feng Y; Sun Y; Hou Y; Yang Z; Guan K; Chen H; Zhang L; Ji H
Nat Commun; 2014 Aug; 5():4629. PubMed ID: 25115923
[TBL] [Abstract][Full Text] [Related]
13. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
14. Roles of microRNA on cancer cell metabolism.
Chen B; Li H; Zeng X; Yang P; Liu X; Zhao X; Liang S
J Transl Med; 2012 Nov; 10():228. PubMed ID: 23164426
[TBL] [Abstract][Full Text] [Related]
15. New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense.
Bao F; Yang K; Wu C; Gao S; Wang P; Chen L; Li H
Fitoterapia; 2018 Mar; 125():123-129. PubMed ID: 29305912
[TBL] [Abstract][Full Text] [Related]
16. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
Vartanian A; Agnihotri S; Wilson MR; Burrell KE; Tonge PD; Alamsahebpour A; Jalali S; Taccone MS; Mansouri S; Golbourn B; Aldape KD; Zadeh G
Oncotarget; 2016 Oct; 7(43):69518-69535. PubMed ID: 27588472
[TBL] [Abstract][Full Text] [Related]
17. HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection.
Tan VP; Miyamoto S
Autophagy; 2015; 11(6):963-4. PubMed ID: 26075878
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
Jin Y; Jiang A; Sun L; Lu Y
BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review.
Sadeghi MS; Lotfi M; Soltani N; Farmani E; Fernandez JHO; Akhlaghitehrani S; Mohammed SH; Yasamineh S; Kalajahi HG; Gholizadeh O
Cancer Cell Int; 2023 Nov; 23(1):284. PubMed ID: 37986065
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1/2.
Liu SS; Li JS; Xue M; Wu WJ; Li X; Chen W
Int J Biol Sci; 2023; 19(8):2599-2612. PubMed ID: 37215997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
